Retrospective Cohort Study
Copyright ©The Author(s) 2025.
World J Gastroenterol. Apr 7, 2025; 31(13): 104046
Published online Apr 7, 2025. doi: 10.3748/wjg.v31.i13.104046
Table 1 Postoperative laboratory and imaging variables of patients with non-alcoholic fatty liver disease or not, n (%)
Variables
Overall (n = 59)
NAFLD group (n = 17)
Not NAFLD group (n = 42)
P value
Surgical procedures0.022
    LPD35 (59.3)14 (40.0)21 (60.0)
    LDPPHRt24 (40.7)3 (12.5)21 (87.5)
Until postoperative 1 month
    Postoperative bleeding7 (11.9)4 (23.5)3 (7.1)0.176
    DGE20 (33.9)5 (29.4)15 (35.7)0.643
    POPF13 (22.0)2 (11.8)11 (26.2)0.388
    SSI1 (1.7)1 (5.9)00.288
Postoperative within 6-12 months
    AST (U/L)23 [17, 32]27 [21, 37]23 [17, 32]0.167
    ALT (U/L)23 [13, 46]23 [15, 49]25 [13, 45]0.657
    AST/ALT1.1 [0.8, 1.5]1.3 [0.9, 1.5]1.1 [0.7, 1.4]0.284
    FIB-4 index1.3 [0.8, 1.9]1.4 [0.8, 1.9]1.1 [0.8, 1.9]0.514
    Albumin (g/L)41.1 [37.2, 45.3]40.5 [35.2, 43.9]41.1 [37.5, 45.5]0.307
    Total cholesterol (mmol/L)3.7 [3.2, 4.3]3.9 [2.8, 4.5]3.7 [3.3, 4.1]0.821
    Random blood glucose(mmol/L)5.6 [5.1, 6.5]6.0 [5.1, 9.5]5.6 [5.1, 6.0]0.312
    TBIL (μmol/L)10.5 [8.0, 15.0]11.0 [8.3, 14.5]10.2 [7.9, 15.0]0.633
    NFS index-2.2 [-3.5, -1.3]-2.1 [-3.7, -0.9]-2.3 [-3.5, -1.5]0.493
    ALP (U/L)87 [70, 129]101 [79, 195]86 [69, 118]0.128